PSMA ligands for PET imaging of prostate cancer
SM Schwarzenboeck, I Rauscher… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Targeting the prostate-specific membrane antigen (PSMA) with 68Ga-labeled and 18F-
labeled PET agents has become increasingly important in recent years. Imaging of …
labeled PET agents has become increasingly important in recent years. Imaging of …
Using PSMA imaging for prognostication in localized and advanced prostate cancer
MJ Roberts, T Maurer, M Perera, M Eiber… - Nature Reviews …, 2023 - nature.com
The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, helping to …
prostate cancer management has evolved rapidly over the past few years, helping to …
18F-FACBC (anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) versus 11C-choline PET/CT in prostate cancer relapse: results of a prospective trial
C Nanni, L Zanoni, C Pultrone, R Schiavina… - European journal of …, 2016 - Springer
Purpose To compare the accuracy of 18 F-FACBC and 11 C-choline PET/CT in patients
radically treated for prostate cancer presenting with biochemical relapse. Methods This …
radically treated for prostate cancer presenting with biochemical relapse. Methods This …
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
I Rauscher, T Maurer, WP Fendler, WH Sommer… - Cancer Imaging, 2016 - Springer
Recently, positron emission tomography (PET) imaging using PSMA-ligands has gained
high attention as a promising new radiotracer in patients with prostate cancer (PC). Several …
high attention as a promising new radiotracer in patients with prostate cancer (PC). Several …
New clinical indications for 18F/11C-choline, new tracers for positron emission tomography and a promising hybrid device for prostate cancer staging: a systematic …
L Evangelista, A Briganti, S Fanti, S Joniau, S Reske… - European urology, 2016 - Elsevier
Context Radiolabelled choline positron emission tomography has changed the
management of prostate cancer patients. However, new emerging radiopharmaceutical …
management of prostate cancer patients. However, new emerging radiopharmaceutical …
Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography …
T Bach-Gansmo, C Nanni, PT Nieh, L Zanoni… - The Journal of …, 2017 - auajournals.org
Purpose: Sensitive detection of cancer foci in men experiencing biochemical recurrence
following initial treatment of prostate cancer is of great clinical significance with a possible …
following initial treatment of prostate cancer is of great clinical significance with a possible …
[HTML][HTML] Prostate cancer–specific PET radiotracers: A review on the clinical utility in recurrent disease
JD Evans, KR Jethwa, P Ost, S Williams… - Practical radiation …, 2018 - Elsevier
Prostate cancer–specific positron emission tomography (pcPET) has been shown to detect
sites of disease recurrence at serum prostate-specific antigen (PSA) levels that are lower …
sites of disease recurrence at serum prostate-specific antigen (PSA) levels that are lower …
Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis
Purpose Many radiotracers are currently available for the detection of recurrent prostate
cancer (rPC), yet many have not been compared head-to-head in comparative imaging …
cancer (rPC), yet many have not been compared head-to-head in comparative imaging …
The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
R Wang, G Shen, M Huang, R Tian - Frontiers in Oncology, 2021 - frontiersin.org
Background Diagnosing the biochemical recurrence (BCR) of prostate cancer (PCa) is a
clinical challenge, and early detection of BCR can help patients receive optimal treatment …
clinical challenge, and early detection of BCR can help patients receive optimal treatment …
Recurrent prostate cancer detection with anti-3-[18F]FACBC PET/CT: comparison with CT
OA Odewole, FI Tade, PT Nieh, B Savir-Baruch… - European journal of …, 2016 - Springer
Purpose To compare the diagnostic performance of the synthetic amino acid analogue PET
radiotracer anti-3-[18 F] FACBC (fluciclovine) with that of CT in the detection of recurrent …
radiotracer anti-3-[18 F] FACBC (fluciclovine) with that of CT in the detection of recurrent …